Skip to content

Clinical trials

beta-Thalassemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: beta-Thalassemia Clear all

263 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20011
20021
20034
20047
20053
20062
20074
20086
20097
20105
20115
201213
20139
201414
20159
20166
201713
201812
201916
202017
202115
202216
202319
202425
202510
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed124
Unknown status52
Recruiting30
Active, not recruiting18
Terminated14
Not yet recruiting11
Enrolling by invitation7
Withdrawn5
Temporarily not available1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assiut University15
Ain Shams University10
Tanta University9
Celgene8
Novartis Pharmaceuticals8
CorrectSequence Therapeutics Co., Ltd5
Institute of Hematology & Blood Diseases Hospital, China5
Nanfang Hospital, Southern Medical University5
National Heart, Lung, and Blood Institute (NHLBI)5
Bioray Laboratories4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
beta-Thalassemia263
Anemia, Sickle Cell58
Thalassemia42
Iron Overload30
Hematologic Diseases19
Hemoglobinopathies18
Anemia12
Genetic Diseases, Inborn12
Anemia, Diamond-Blackfan10
Myelodysplastic Syndromes9

Trials

Showing 1 to 25 of 263. Each trial links to its page on Pharma Observatory.

163 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.